Research progress on ultrasound medicine in diagnosis and evaluation of chemotherapy effect of breast cancer
DOI:
https://doi.org/10.62051/7dr25v26Keywords:
breast cancer; ultrasonography; diagnosis; neoadjuvant chemotherapy.Abstract
Breast cancer has the highest incidence rate among cancers in the world and is the main cause of death among female cancer patients around the world. The progress of ultrasound technology has continuously improved the ability to identify the shape and microvessels of breast masses. It plays an important role in the differentiation of benign and malignant breast masses and is the main auxiliary diagnostic method for breast cancer. The widespread implementation of neoadjuvant chemotherapy for breast cancer has improved the survival rate of patients. Evaluating the efficacy after chemotherapy and adjusting chemotherapy strategies as needed can help improve the prognosis of patients. Ultrasound can conduct multi-parameter measurements of breast tumor hardness, blood flow velocity and vascular distribution, which can be applied to evaluate the efficacy of neoadjuvant chemotherapy for breast cancer. This article reviewed the application and research progress of multi-modal ultrasound in the diagnosis and evaluation of chemotherapy efficacy of breast cancer.
Downloads
References
Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. CA Cancer J Clin. Vol. 73 (2023) No. 1, p. 17-48.
Henry-Tillman R, Kabongo M, Laryea J, et al. The Ability to Look: Management of Breast Disease in the Democratic Republic of the Congo Using Smart Ultrasound Technology. J Am Coll Surg. Vol. 232 (2021) No. 4, p. 636-640.
Saadatmand S, Bretveld R, Siesling S, et al. Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients. BMJ. Vol. 351 (2015) p. h4901.
Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. Vol. 225 (2002) No. 1, p. 165-175.
Berg WA, Bandos AI, Mendelson EB, et al. Ultrasound as the Primary Screening Test for Breast Cancer: Analysis From ACRIN 6666. J Natl Cancer Inst. Vol. 108 (2015) No. 4, p. djv367.
Lee S, Jung Y, Bae Y. Clinical application of a color map pattern on shear-wave elastography for invasive breast cancer. Surg Oncol. Vol. 25 (2016) No. 1, p. 44-48. Vol. () No. , p. .
Kapetas P, Clauser P, Woitek R, et al. Quantitative Multiparametric Breast Ultrasound: Application of Contrast-Enhanced Ultrasound and Elastography Leads to an Improved Differentiation of Benign and Malignant Lesions. Invest Radiol. Vol. 54 (2019) No. 5, p. 257-264.
Choi JS, Han BK, Ko EY, et al. Additional diagnostic value of shear-wave elastography and color Doppler US for evaluation of breast non-mass lesions detected at B-mode US. Eur Radiol. Vol. 26 (2016) No. 10, p. 3542-3549.
Huppe AI, Inciardi MF, Aripoli AM, et al. Pearls and Pitfalls of Interpretation of Automated Breast US. Radiographics. Vol. 43 (2023) No. 10, e230023.
Moon WK, Lee YW, Ke HH, et al. Computer-aided diagnosis of breast ultrasound images using ensemble learning from convolutional neural networks. Comput Methods Programs Biomed. Vol. 190 (2020) , 105361.
Shen Y, Shamout FE, Oliver JR, et al. Artificial intelligence system reduces false-positive findings in the interpretation of breast ultrasound exams. Nat Commun. Vol. 12 (2021) No. 1, 5645.
Wang Y, Wang N, Xu M, et al. Deeply-Supervised Networks With Threshold Loss for Cancer Detection in Automated Breast Ultrasound. IEEE Trans Med Imaging. Vol. 39 (2020) No. 4, p. 866-876.
Sprague BL, Stout NK, Schechter C, et al. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med. Vol. 162 (2015) No. 3, p. 157-166.
Lee SH, Chung J, Choi HY, et al. Evaluation of Screening US-detected Breast Masses by Combined Use of Elastography and Color Doppler US with B-Mode US in Women with Dense Breasts: A Multicenter Prospective Study. Radiology. Vol. 285 (2017) No. 2, p. 660-669.
Pavlov MV, Bavrina AP, Plekhanov VI, et al. Changes in the tumor oxygenation but not in the tumor volume and tumor vascularization reflect early response of breast cancer to neoadjuvant chemotherapy. Breast Cancer Res. Vol. 25 (2023) No. 1, 12.
Li JK, Fu NQ, Wang B, et al. Conventional ultrasound combined with contrast-enhanced ultrasound: could it be helpful for the diagnosis of thoracic wall recurrence after mastectomy? Eur Radiol. Vol. 33 (2023) No. 9, p. 6482-6491.
Ternifi R, Wang Y, Gu J, et al. Ultrasound high-definition microvasculature imaging with novel quantitative biomarkers improves breast cancer detection accuracy. Eur Radiol. Vol. 32 2022() No. 11, p. 7448-7462.
Yao Z, Luo T, Dong Y, et al. Virtual elastography ultrasound via generative adversarial network for breast cancer diagnosis. Nat Commun. Vol. 14 (2023) No. 1, 788.
Xiao X, Jiang Q, Wu H, et al. Diagnosis of sub-centimetre breast lesions: combining BI-RADS-US with strain elastography and contrast-enhanced ultrasound-a preliminary study in China. Eur Radiol. Vol. 27 (2017) No. 6, p. 2443-2450.
Sadigh G, Carlos RC, Neal CH, et al. Ultrasonographic differentiation of malignant from benign breast lesions: a meta-analytic comparison of elasticity and BIRADS scoring. Breast Cancer Res Treat. Vol. 133 (2012) No. 1, p. 23-35.
Barr RG, Zhang Z. Shear-wave elastography of the breast: value of a quality measure and comparison with strain elastography. Radiology. Vol. 275 (2015) No. 1, p. 45-53.
Yang Q, Fu Y, Wang J, Yang H, et al. Advantages of contrast-enhanced ultrasound in the localization and diagnostics of sentinel lymph nodes in breast cancer. J Zhejiang Univ Sci B. Vol. 24 (2023) No. 11, p. 985-997.
Balleyguier C, Opolon P, Mathieu MC, et al. New potential and applications of contrast-enhanced ultrasound of the breast: Own investigations and review of the literature. Eur J Radiol. Vol. 69 (2009) No. 1, p. 14-23.
Xia HS, Wang X, Ding H, et al. Papillary breast lesions on contrast-enhanced ultrasound: morphological enhancement patterns and diagnostic strategy. Eur Radiol. Vol. 24 (2014) No. 12, p. 3178-3190.
Xu Z, Wang Y, Chen M, et al. Multi-region radiomics for artificially intelligent diagnosis of breast cancer using multimodal ultrasound. Comput Biol Med. Vol. 149 (2022), 105920.
Jiang J, Chen YQ, Xu YZ, et al. Correlation between three-dimensional ultrasound features and pathological prognostic factors in breast cancer. Eur Radiol. Vol. 24 (2014) No. 6, p. 1186-1196.
Alcázar JL. Three-dimensional power Doppler derived vascular indices: what are we measuring and how are we doing it? Ultrasound Obstet Gynecol. Vol. 32 (2008) No. 4, p. 485-487.
Nieuwenhuis LL, Keizer AL, Stoelinga B, et al. Fibroid vascularisation assessed with three-dimensional power Doppler ultrasound is a predictor for uterine fibroid growth: a prospective cohort study. BJOG. Vol. 125 (2018) No. 5, p. 577-584.
Kalmantis K, Dimitrakakis C, Koumpis Ch, et al. The contribution of three-dimensional power Doppler imaging in the preoperative assessment of breast tumors: a preliminary report. Obstet Gynecol Int. Vol. 2009 (2009) , 530579.
Hu Z, Cheng X, Li J, et al. Preliminary study of real-time three-dimensional contrast-enhanced ultrasound of sentinel lymph nodes in breast cancer. Eur Radiol. Vol. 30 (2020) No. 3, p. 1426-1435.
Spear GG, Mendelson EB. Automated breast ultrasound: Supplemental screening for average-risk women with dense breasts. Clin Imaging. Vol. 76 (2021), p. 15-25.
Wang Y, Wang N, Xu M, et al. Deeply-Supervised Networks With Threshold Loss for Cancer Detection in Automated Breast Ultrasound. IEEE Trans Med Imaging. Vol. 39 (2020) No. 4, p. 866-876.
Lee CI, Chen LE, Elmore JG. Risk-based Breast Cancer Screening: Implications of Breast Density. Med Clin North Am. Vol. 101 (2017) No. 4, p. 725-741.
Vourtsis A, Kachulis A. The performance of 3D ABUS versus HHUS in the visualisation and BI-RADS characterisation of breast lesions in a large cohort of 1,886 women. Eur Radiol. Vol. 28 (2018) No. 2, p. 592-601.
Zhou Y, Chen H, Li Y, et al. Multi-task learning for segmentation and classification of tumors in 3D automated breast ultrasound images. Med Image Anal. Vol. 70 (2021), 101918.
Yu TF, He W, Gan CG, et al. Deep learning applied to two-dimensional color Doppler flow imaging ultrasound images significantly improves diagnostic performance in the classification of breast masses: a multicenter study. Chin Med J (Engl). Vol. 134 (2021) No. 4, p. 415-424.
Afrin H, Larson NB, Fatemi M, et al. Deep Learning in Different Ultrasound Methods for Breast Cancer, from Diagnosis to Prognosis: Current Trends, Challenges, and an Analysis. Cancers (Basel). Vol. 15 (2023) No. 12, 3139.
Ansari MY, Qaraqe M, Righetti R, et al. Unveiling the future of breast cancer assessment: a critical review on generative adversarial networks in elastography ultrasound. Front Oncol. Vol. 13 (2023), 1282536.
Ding R, Xiao Y, Mo M, et al. Breast cancer screening and early diagnosis in Chinese women. Cancer Biol Med. Vol. 19 (2022) No. 4, p. 450–467.
Kim MJ, Kim JY, Yoon JH, et al. How to find an isoechoic lesion with breast US. Radiographics. Vol. 31 (2011) No. 3, p. 663-676.
Chen C, Wang Y, Niu J, et al. Domain Knowledge Powered Deep Learning for Breast Cancer Diagnosis Based on Contrast-Enhanced Ultrasound Videos. IEEE Trans Med Imaging. Vol. 40 (2021) No. 9, p. 2439-2451.
Chen J, Ma J, Li C, et al. Multi-parameter ultrasonography-based predictive model for breast cancer diagnosis. Front Oncol. Vol. 12 (2022), 1027784.
Rotten D, Levaillant JM, Zerat L. Analysis of normal breast tissue and of solid breast masses using three-dimensional ultrasound mammography. Ultrasound Obstet Gynecol. Vol. 14 (1999) No. 2, p. 114-124.
Qian X, Zhang B, Liu S, et al. A combined ultrasonic B-mode and color Doppler system for the classification of breast masses using neural network. Eur Radiol. Vol. 30 (2020) No. 5, p. 3023-3033.
Kim MJ, Eun NL, Ahn SG, et al. Elasticity Values as a Predictive Modality for Response to Neoadjuvant Chemotherapy in Breast Cancer. Cancers (Basel). Vol. 16 (2024) No. 2, 377.
Guo J, Wang BH, He M, et al. Contrast-enhanced ultrasonography for early prediction of response of neoadjuvant chemotherapy in breast cancer. Front Oncol. Vol. 12 (2022), 1026647.
Qi J, Wang C, Ma Y, et al. The potential role of combined shear wave elastography and superb microvascular imaging for early prediction the pathological response to neoadjuvant chemotherapy in breast cancer. Front Oncol. Vol. 13 (2023), 1176141.
Chen Y, Qi Y, Wang K. Neoadjuvant chemotherapy for breast cancer: an evaluation of its efficacy and research progress. Front Oncol. Vol. 13 (2023), 1169010.
Elsayed B, Alksas A, Shehata M, et al. Exploring Neoadjuvant Chemotherapy, Predictive Models, Radiomic, and Pathological Markers in Breast Cancer: A Comprehensive Review. Cancers (Basel). Vol. 15 (2023) No. 21, 5288.
Ma Y, Zhang S, Li J, et al. Comparison of strain and shear-wave ultrasounic elastography in predicting the pathological response to neoadjuvant chemotherapy in breast cancers. Eur Radiol. Vol. 27 (2017) No. 6, p. 2282-2291.
Pavlov MV, Bavrina AP, Plekhanov VI, et al. Changes in the tumor oxygenation but not in the tumor volume and tumor vascularization reflect early response of breast cancer to neoadjuvant chemotherapy. Breast Cancer Res. Vol. 25 (2023) No. 1, 12.
Singh G, Kumar P, Parshad R, et al. Role of color Doppler indices in predicting disease-free survival of breast cancer patients during neoadjuvant chemotherapy. Eur J Radiol. Vol. 75 (2010) No. 2, p. 158-162.
Kumar A, Singh S, Pradhan S, et al. Doppler ultrasound scoring to predict chemotherapeutic response in advanced breast cancer. World J Surg Oncol. Vol. 5 (2007), 99.
Saracco A, Szabó BK, Tánczos E, et al. Contrast-enhanced ultrasound (CEUS) in assessing early response among patients with invasive breast cancer undergoing neoadjuvant chemotherapy. Acta Radiol. Vol. 58 (2017) No. 4, p. 394-402.
Downloads
Published
Conference Proceedings Volume
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.